Development of Multifunctional Magnetic Nanoparticles for Genetic Engineering and Tracking of Neural Stem Cells

Genetic modification of cell transplant populations and cell tracking ability are key underpinnings for effective cell therapies. Current strategies to achieve these goals utilize methods which are unsuitable for clinical translation because of related safety issues, and multiple protocol steps addi...

Full description

Saved in:
Bibliographic Details
Published inAdvanced healthcare materials Vol. 5; no. 7; p. 841
Main Authors Adams, Christopher, Israel, Liron Limor, Ostrovsky, Stella, Taylor, Arthur, Poptani, Harish, Lellouche, Jean-Paul, Chari, Divya
Format Journal Article
LanguageEnglish
Published Germany 06.04.2016
Subjects
Animals
Biomarkers - metabolism
Cell Differentiation
Cell Tracking - methods
DNA - metabolism
Magnetic Resonance Imaging
Magnetite Nanoparticles - chemistry
Mice
Neural Stem Cells - cytology
Particle Size
Polyethyleneimine - chemistry
Regeneration
Static Electricity
Transfection
cell transplantation
magnetic nanoparticle
magnetic resonance imaging
magnetofection
cell tracking
Online AccessGet more information

Cover

More Information
Summary:Genetic modification of cell transplant populations and cell tracking ability are key underpinnings for effective cell therapies. Current strategies to achieve these goals utilize methods which are unsuitable for clinical translation because of related safety issues, and multiple protocol steps adding to cost and complexity. Multifunctional magnetic nanoparticles (MNPs) offering dual mode gene delivery and imaging contrast capacity offer a valuable tool in this context. Despite their key benefits, there is a critical lack of neurocompatible and multifunctional particles described for use with transplant populations for neurological applications. Here, a systematic screen of MNPs (using a core shown to cause contrast in magnetic resonance imaging (MRI)) bearing various surface chemistries (polyethylenimine (PEI) and oxidized PEI and hybrids of oxidized PEI/alginic acid, PEI/chitosan and PEI/polyamidoamine) is performed to test their ability to genetically engineer neural stem cells (NSCs; a cell population of high clinical relevance for central nervous system disorders). It is demonstrated that gene delivery to NSCs can be safely achieved using two of the developed formulations (PEI and oxPEI/alginic acid) when used in conjunction with oscillating magnetofection technology. After transfection, intracellular particles can be detected by histological procedures with labeled cells displaying contrast in MRI (for real time cell tracking).
ISSN:2192-2659
DOI:10.1002/adhm.201500885